{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicdqcx225oy27jfidabdkajiy43vyr6r4dsvmljywlzrl7cpoxdbm",
    "uri": "at://did:plc:empjqd66qnuzjesut6yhsux4/app.bsky.feed.post/3mj5u7qviaud2"
  },
  "path": "/boerse/news/ueberblick/dexcom-inc-stock-us2521311074-is-continuous-glucose-monitoring-strong/69119633",
  "publishedAt": "2026-04-10T17:30:31.000Z",
  "site": "https://www.ad-hoc-news.de",
  "textContent": "Dexcom leads in real-time diabetes tech that's changing lives and markets for millions of U.S. patients. For investors eyeing healthcare growth amid aging demographics, this Nasdaq stock offers a focused play on innovation. ISIN: US2521311074",
  "title": "Dexcom Inc. stock (US2521311074): Is continuous glucose monitoring strong enough to drive U.S. investor upside?",
  "updatedAt": "2026-04-10T17:30:31.000Z"
}